SCHEMBL7944093

SCHEMBL7944093

CCCn1c(=O)c(C(F)(F)F)nc2c(N)cc(NCc3c(F)cccc3F)nc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STIM1 Q13586 1/20 0.38
ORAI1 Q96D31 1/20 0.38
TLR9 Q9NR96 1/20 0.35
ADORA2B P29275 3/20 0.35
ALDH1A1 P00352 2/20 0.34
CD38 P28907 3/20 0.34
TMIGD3 P0DMS9 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
CYP3A4 P08684 1/20 0.34
KCNH2 Q12809 1/20 0.34
POLB P06746 1/20 0.33
CCNT1 O60563 1/20 0.33
CDK9 P50750 1/20 0.33
SCD O00767 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
KMT2A Q03164 1/20 0.32
ABL1 P00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7943760 0.87 CD38 (0.37) STIM1ORAI1ADORA2BALDH1A1CD38
SCHEMBL7945503 0.84 TLR9 (0.37) TLR9ADORA2BALDH1A1TMIGD3ADORA2A
SCHEMBL7937861 0.81 TLR9 (0.35) TLR9ADORA2BTMIGD3ADORA2AADORA1
SCHEMBL3227728 0.81 SCN8A (0.37) STIM1ORAI1ALDH1A1CD38CYP3A4
SCHEMBL7937752 0.80 ADORA2A (0.39) ADORA2BALDH1A1ADORA2AADORA1CYP3A4
SCHEMBL7946084 0.66 HRH4 (0.37) TLR9ADORA2BALDH1A1ADORA2AADORA1
SCHEMBL7943995 0.62 HSF1 (0.36) ALDH1A1ADORA2AADORA1CYP3A4MEN1
SCHEMBL7937747 0.61 HSF1 (0.35) ALDH1A1ADORA2AADORA1CYP3A4MEN1
SCHEMBL7938416 0.60 CYP1A2 (0.50) ALDH1A1CYP3A4MEN1KMT2A
SCHEMBL7944574 0.59 HSF1 (0.36) ADORA2BADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010008775-A1 AMINOPYRIDOPYRAZINONE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES LIGAND PHARMACEUTICALS INC. (US) 2010-01-21 WO disclosed